Enhancement of the anticancer effect of atorvastatin-loaded nanoemulsions by improving oral absorption via multivalent intestinal transporter-targeting lipids

Atorvastatin (ATV) has attracted considerable attention as a potential therapeutic agent for cancer because it inhibits cancer cell proliferation by suppressing the mevalonate pathway. However, because of its low oral absorption, high doses of ATV are required for chemotherapeutic applications. In t...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak: Laxman Subedi, Prashant Pandey, Bikram Khadka, Jung-Hyun Shim, Seung-Sik Cho, Seho Kweon, Youngro Byun, Ki-Taek Kim, Jin Woo Park
Formatua: Artikulua
Hizkuntza:English
Argitaratua: Taylor & Francis Group 2022-12-01
Saila:Drug Delivery
Gaiak:
Sarrera elektronikoa:https://www.tandfonline.com/doi/10.1080/10717544.2022.2149896